Clinical Trial Update: Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt [Phase 3]

View source ↗

Summary

Phase 3 trial update on coadministration of ABT-450/Ritonavir/ABT-267 with Ribavirin in adults with genotype 4 hepatitis C in Egypt; study completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• ABT-450/Ritonavir/ABT-267 (ABT-450/ritonavir/ABT-267)
• Ribavirin (ribavirin)

Snippet

Sponsor: AbbVie | Conditions: HCV, Hepatitis C Infection | Phase 3 | Status: COMPLETED | Results posted: 2017-07-27